Seqanswers Leaderboard Ad

Collapse

Announcement

Collapse
No announcement yet.
X
 
  • Filter
  • Time
  • Show
Clear All
new posts

  • MiSeq sample volume, recover leftover library after run?

    A MiSeq run needs 600 ul of denatured library. However, about 415 ul of library remains after the run has completed (measured after a v3-600 run). Would it be possible to load a smaller volume? If used in combination with the NextSeq denaturation protocol, a smaller volume would enable a higher cluster density from low-yield samples. This would only work if the sipper goes deep enough into the tube containing the library.

    Another (crazy?) thought is to recover the leftover, denatured library, and re-use it in another run if needed, unless there is some sort of backflow or mixing from other wells back into the sample well. Again this only makes sense for low-yield, precious libraries. Any thoughts?

    An additional thought; PCR-free library protocols are generally (always?) less biased, but require large amounts of input DNA. The approach with NextSeq denaturation, and possibly less dilution before loading into the cassette, could potentially generate usable libraries from smaller starting amounts of DNA. That seems like a better solution than adding a PCR enrichment step as I discussed here.

    Jon
    Last edited by JBKri; 10-22-2015, 08:38 AM.

  • #2
    Almost all of that volume is water from the template rinse.

    Comment


    • #3
      Originally posted by kcchan View Post
      Almost all of that volume is water from the template rinse.
      Ah, I see. So my idea wouldn't work. Thanks!

      Comment

      Latest Articles

      Collapse

      • seqadmin
        Understanding Genetic Influence on Infectious Disease
        by seqadmin




        During the COVID-19 pandemic, scientists observed that while some individuals experienced severe illness when infected with SARS-CoV-2, others were barely affected. These disparities left researchers and clinicians wondering what causes the wide variations in response to viral infections and what role genetics plays.

        Jean-Laurent Casanova, M.D., Ph.D., Professor at Rockefeller University, is a leading expert in this crossover between genetics and infectious...
        09-09-2024, 10:59 AM
      • seqadmin
        Addressing Off-Target Effects in CRISPR Technologies
        by seqadmin






        The first FDA-approved CRISPR-based therapy marked the transition of therapeutic gene editing from a dream to reality1. CRISPR technologies have streamlined gene editing, and CRISPR screens have become an important approach for identifying genes involved in disease processes2. This technique introduces targeted mutations across numerous genes, enabling large-scale identification of gene functions, interactions, and pathways3. Identifying the full range...
        08-27-2024, 04:44 AM

      ad_right_rmr

      Collapse

      News

      Collapse

      Topics Statistics Last Post
      Started by seqadmin, Today, 06:25 AM
      0 responses
      13 views
      0 likes
      Last Post seqadmin  
      Started by seqadmin, Yesterday, 01:02 PM
      0 responses
      12 views
      0 likes
      Last Post seqadmin  
      Started by seqadmin, 09-18-2024, 06:39 AM
      0 responses
      14 views
      0 likes
      Last Post seqadmin  
      Started by seqadmin, 09-11-2024, 02:44 PM
      0 responses
      14 views
      0 likes
      Last Post seqadmin  
      Working...
      X